Joseph Rai

TPG Growth leads Series C funding in Strides' biopharma division

Healthcare

19 March, 2021

TPG Growth leads Series C funding in Strides' biopharma division

Stelis Biopharma, a division of Mumbai-listed Strides Pharma Science, has raised $125 million (Rs 907 crore) as part of its ......

TMT

18 March, 2021

IvyCap Ventures invests in online apparel firm Bewakoof

Bewakoof, a direct-to-consumer (D2C) online apparel company, on Thursday said it has raised $4 million (Rs 29 crore) from IvyCap...

Premium

Healthcare

18 March, 2021

Sequoia-backed pharma firm's CEO quits to float venture

The CEO and co-founder of Sequoia Capital-backed pharmaceuticals company has quit to float his business, a person familiar with...

TMT

18 March, 2021

Micro VC firm Eximius hits first close of debut $10 mn fund

Micro venture capital firm Eximius Ventures on Thursday said it has marked the first close of its debut fund that ......

Premium

People

17 March, 2021

IIFL's asset management unit exec quits to float own venture

A top executive at IIFL's asset management group has quit after over a decade with the financial services company to ......

Premium

Healthcare

16 March, 2021

Max Healthcare buys out PE investor from hospital firm

Hospital chain operator Max Healthcare Institute has bought out a private equity investor from a healthcare firm. It said it...

Premium

Infrastructure

15 March, 2021

Motilal Oswal PE exits power exchange

Motilal Oswal Private Equity (MOPE) has exited its investment from a power exchange after five years, having made over three ......

Healthcare

15 March, 2021

Dr Lal PathLabs managing director joins NephroPlus as independent director

Dialysis chain NephroPlus, backed by Bahrain-based private equity firm Investcorp, on Monday said a top executive from India's...

Consumer

12 March, 2021

Verlinvest leads Series A funding in personal care brand Juicy Chemistry

Juicy Chemistry, an organic personal care brand, said it has raised $6.3 million (Rs 45.7 crore) as part of its ......

Premium

Healthcare

11 March, 2021

Homegrown drugmaker, PE firm among suitors for Samara Capital's pharma platform

Samara Capital’s pharma platform has received interest from the country’s top drug maker and a homegrown private equity...